Literature DB >> 29632750

Use of Femoral and Sciatic Nerve Block Combination in Severe Emphysematous Lung Disease for Femoral Popliteal Arterial Bypass Surgery.

Onur Selvi1, Olgar Bayserke2, Serkan Tulgar3.   

Abstract

Regional anesthesia is a widely used anesthesia technique for high-risk patients with severe vascular or pulmonary diseases in which general anesthesia is considered harmful and should be avoided. In this case, we present the use of femoral-sciatic nerve block combination for a 65-year-old, ASA IV, male patient who had severe emphysematous lung disease and was planned for a right femoral-popliteal arterial bypass surgery. He had severe pulmonary disease, hypertension, peripheral vascular disease, and was on clopidogrel treatment. Due to his existing comorbidities, regional anesthesia was considered the right method. The combination of femoral and sciatic nerve block was successfully used for the operation, which lasted for one hour and fifty minutes under sedation, and was continuously supplied with a propofol infusion. The patient was safely discharged to the surgical ward with no pain. The femoral block and sciatic block combination is described as one of the most useful, and at the same time, the most ignored anesthetic method. This technique is considered a standard technique and is often taught early in training; however, its use seems to be underestimated as there are only a few cases documented in Turkey. The aim of this case is to serve as a reminder of its significant value in patients who are not appropriate for general anesthesia and neuraxial blocks.

Entities:  

Keywords:  nerve block; vascular surgery

Year:  2018        PMID: 29632750      PMCID: PMC5880585          DOI: 10.7759/cureus.2140

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  8 in total

Review 1.  New concepts of atelectasis during general anaesthesia.

Authors:  L Magnusson; D R Spahn
Journal:  Br J Anaesth       Date:  2003-07       Impact factor: 9.166

Review 2.  Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology.

Authors:  Wiebke Gogarten; Erik Vandermeulen; Hugo Van Aken; Sibylle Kozek; Juan V Llau; Charles M Samama
Journal:  Eur J Anaesthesiol       Date:  2010-12       Impact factor: 4.330

3.  Combined sciatic and femoral nerve blocks for infrainguinal arterial bypass surgery: a case series.

Authors:  Alexander Yazigi; Samia Madi-Gebara; Fadia Haddad; Gemma Hayeck; Georges Tabet
Journal:  J Cardiothorac Vasc Anesth       Date:  2005-04       Impact factor: 2.628

4.  High volume and low concentration of anaesthetic solution in the perivascular interscalene sheath determines quality of block and incidence of complications.

Authors:  P Pippa; P Cuomo; A Panchetti; M Scarchini; G Poggi; M D'Arienzo
Journal:  Eur J Anaesthesiol       Date:  2006-07-11       Impact factor: 4.330

Review 5.  The analgesic efficacy of sciatic nerve block in addition to femoral nerve block in patients undergoing total knee arthroplasty: a systematic review and meta-analysis.

Authors:  S Grape; K R Kirkham; M Baeriswyl; E Albrecht
Journal:  Anaesthesia       Date:  2016-07-29       Impact factor: 6.955

6.  Long-term outcome of infrainguinal bypass grafting in patients with serologically proven hypercoagulability.

Authors:  Michael A Curi; Christopher L Skelly; Zachary K Baldwin; David H Woo; Joseph M Baron; Tina R Desai; Daniel Katz; James F McKinsey; Hisham S Bassiouny; Bruce L Gewertz; Lewis B Schwartz
Journal:  J Vasc Surg       Date:  2003-02       Impact factor: 4.268

7.  [Anesthesia for lower extremity vascular bypass with peripheral nerve block].

Authors:  Jordana de Fraga Guimarães; Cristine Formighieri Angonese; Rafael Klein Gomes; Vasco Miranda Junior; Carlos Farias
Journal:  Rev Bras Anestesiol       Date:  2016-01-23       Impact factor: 0.964

8.  Lower limb surgeries under combined femoral and sciatic nerve block.

Authors:  Lipsy Bansal; Joginder Pal Attri; Pawan Verma
Journal:  Anesth Essays Res       Date:  2016 Sep-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.